Skip to main content
. 2020 Nov 13;222:108630. doi: 10.1016/j.clim.2020.108630

Table 1.

Demographics and clinical characteristics of study population.

HDs (n = 19) COVID-19 subjects (n = 45) Severe (n = 14) Non-severe (n = 31) p value
Characteristics
 Age, median (IRQ) years 61 (55.5–66.0) 62 (54.3–75.0) 71 (62.3–85.5) 58 (52.0–66.0) 0.017a
 Male/Female 7/12 17/28 8/6 9/22 0.072a
 Smoking 5 4 1 3 nsa
 Incubation period (days) 9 (5–10.5) 7 (6.3–10) 9 (5–11) nsa
Comorbid condition
 Any 26 12 14 0.021a
 Chronical obstructive pulmonary disease 4 3 1
 Hypertension 16 7 9
 Cardiovascular disease 7 4 3
 Diabetes 7 3 4
 Malignant tumor 7 3 4
 Dyslipidemia 6 3 3
 Obesity 5 2 3
Signs and symptoms
 Fever 35 12 23
 Dry cough 20 4 16
 Shortness of breath 9 5 4
 Confusion 1 1 0
 Anosmia and ageusia 3 2 1
Laboratory findings
 WBC (x 109/L) (4.4–11.3)c 4.8 (3.5–5.8) 5.4 (4.6–8.0) 4.2 (3.3–5.7) 0.061b
 Lymphocytes (x 109/L) (1.0–4.8)c 1.0 (0.8–1.3) 0.9 (0.6–1.2) 1.0 (0.8–1.3) nsb
 CRP (mg/dl) (0.0–0.6)c 3.5 (1.7–10.6) 9.6 (4.2–16.6) 2.2 (0.8–5.2) 0.002b
 P/F ratio >400c 329 (248–438) 177 (143–248) 383 (315.3–470) <0.0001b
 AST (UI/L) (9-45)c 21 (17–31) 31 (21.8–53) 18.5 (14.8–24.5) 0.0006b
 Ferritin (ng/ml) (12−300)c 473 (235.3–816) 871 (268–3044) 466 (227–583) nsb
 LDH (U/L) (135-225)c 257 (204–310) 404 (269.5–438) 241 (185.5–272.5) <0.0001b
 D-dimer (μg/ml) (50-420)c 932 (486–1733) 1612 (1331–2382) 598.5 (433.3–1012) 0.001b

HDs: healthy donors, IQR: interquartile range, CRP: C-reactive protein, WBC: white blood cells, P/F: PaO2/FiO2, AST: aspartate aminotransferase, LDH: lactate dehydrogenase.

Bold indicates p value significant.

a

The 2-tailed χ2 test or Fisher's exact test was used for comparing proportions between severe and non-severe groups.

b

The nonparametric comparative Mann-Whitney test was used to compare medians between severe and non-severe groups.

c

Normal range of laboratory findings in healthy donors.